Abstract CT076: A Phase 1, first-in-human study of IB-T101, an OUTLAST™ CAR-T product for the treatment of CD70-positive clear cell renal carcinoma
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Warren Anderson, Bo Liu, Yuning Lei, Jun Cui, Yarong Liu, Kevin Carbajal, Matthias Schroff, Maximilian Richter
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7154688341
Cites:
Cited by:
Related to: